The price of Nituzumab Injection may be around $2,000, and the common price ranges from $1,435 to $1,987, depending on the region, manufacturer and specifications. Nituzumab is mainly used in the clinic for the combination of radiotherapy for the treatment of stage III/IV nasopharyngeal carcinoma with positive epidermal growth factor receptor expression. Adverse reactions associated with this product are mainly characterized by mild fever, decreased blood pressure, nausea, dizziness and rash. It needs to be contraindicated for those who are allergic to nitolizumab injection or any of its components. Because it crosses the placental barrier, it should be used with caution in pregnant women or women who are not using effective contraception. Safety and efficacy have not been studied in children and the elderly and its use is not recommended. It is recommended to use Nitolizumab Injection under medical supervision.